Table 1.
Molecular target | Mechanism of action | Approved agent |
---|---|---|
Prenylation | Osteolysis inhibitor | Zoledronic acid and other bisphosphonates |
RANK/RANKL/OPG axis | Osteoclastogenesis inhibitor | Denosumab |
Recombinant osteoprotegerin (OPG) | Osteoclastogenesis inhibitor | |
STA-21 (STAT-3 inhibitor) | Osteoclastogenesis inhibitor | |
TGF-beta | Osteoclastogenesis inhibitor | |
Alpha2/Beta1 integrin | Bone homing and drug vehicles |